神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)
CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)
Intermediate Filament Protein
- 編號(hào)SCA068Ra
- 物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)2h, 40min
- 檢測(cè)范圍4.12-3,000pg/mL
- 靈敏度最小可檢測(cè)劑量小于等于1.41pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價(jià)格 ¥ 3830 ¥ 5472 ¥ 24624 ¥ 46512 ¥ 383040
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測(cè)神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP),經(jīng)檢測(cè)與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 84-91 | 87 |
EDTA plasma(n=5) | 81-91 | 85 |
heparin plasma(n=5) | 94-103 | 101 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)含量的測(cè)定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 91-99% | 96-104% | 95-103% | 97-104% |
EDTA plasma(n=5) | 87-94% | 89-96% | 93-101% | 83-94% |
heparin plasma(n=5) | 81-94% | 80-99% | 86-102% | 86-95% |
穩(wěn)定性
經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
3. 吸棄,加檢測(cè)溶液A100μL,37°C孵育1小時(shí);
4. 洗板3次;
5. 加檢測(cè)溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加底物100µL,37°C孵育10分鐘;
8. 讀數(shù)。
實(shí)驗(yàn)原理
將神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入底物。加入底物后會(huì)產(chǎn)生輝光型光信號(hào)。發(fā)射光強(qiáng)度和樣品中的神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)呈正相關(guān)。用化學(xué)發(fā)光儀測(cè)定相對(duì)光單位(RLU),計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA068Ra02 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA068Ra01 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA068Ra02 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)多克隆抗體 | WB; IHC; ICC; IP. |
PAA068Ra01 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)多克隆抗體 | WB; IHC; ICC; IP. |
LAA068Ra71 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
LAA068Ra81 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
MAA068Ra24 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra25 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra28 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra23 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra22 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra29 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra21 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
MAA068Ra27 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
SEA068Ra | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA068Ra | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA068Ra | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA068Ra01 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
CGA068Ra02 | 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)cDNA | PCR、蛋白表達(dá)等 |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Occupational Health | Effects of Exposure to 1-Bromopropane on Astrocytes and Oligodendrocytes in Rat Brain [Pubmed: 23183024] |
Morfovirtual 2014 | EFECTO PROTECTOR DEL TRATAMIENTO CON NEUROEPO SOBRE LA GLIA DE LA CORTEZA CEREBRAL EN RATONES TRANSGéNICOS CON LA ENFERMEDAD DE ALZHEIMER. [Sld:Source] |
Annals of Anatomy | Effect of memantine, a NMDA receptor blocker, on ethambutol-induced retinal injury [PubMed: 26704355] |
Mediators of Inflammation | IL-4 Inhibits IL-1β-Induced Depressive-Like Behavior and Central Neurotransmitter Alterations [PubMed: 26417153] |
Neurochem Res | Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat [PubMed: 26700436] |
Cell Mol Neurobiol | Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease [PubMed: 26119304] |
Sleep and Biological Rhythms | Relationship of orexin (hypocretin) system and astrocyte activation in Parkinson's disease with hypersomnolence [Doi: 10.1111] |
Cellular and Molecular Neurobiology | Hypericum Perforatum?Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease [Pubmed:26119304] |
Ann Anat | Effect of memantine: A NMDA receptor blocker, on ethambutol-induced retinal injury [Pubmed:26704355] |
United States Patent Application | ESTROGENIC COMPONENTS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS [y2016:0101116.html] |
Clinical Research | Human plasma glial fibrillary acidic protein and heat shock protein 27 concentrations in acute moderate-intensity aerobic exercise with different duration [a825e1e27b0221df9a627769c0f614432e92.pdf] |
Medical Journal of Indonesia | Comparison of GFAP and HSP27 concentrations in acute moderate-intensity aerobic exercise of different duration [2031884] |
Peptides. | Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: Possible involved mechanisms. [pubmed:27777064] |
european journal of pharmacology | Garlic active constituent s-allyl cysteine protects against lipopolysaccharide-induced cognitive deficits in the rat: Possible involved mechanisms. [pubmed:27915041] |
european journal of pharmacology | Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling. [pubmed:28284752] |
biomedicine & pharmacotherapy | Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat. [pubmed:28199883] |
J Endocrinol.? | Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study. [pubmed:27799463] |
IOS Press Content Library | An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's … [articles:journal-of-alzheimers-disease] |
Tier?rztliche Hochschule Hannover | Evaluierung von Biomarkern im Liquor cerebrospinalis bei paraplegischen Hunden mit Ru?ckenmarksverletzung [:] |
Nigerian Journal of Clinical Practice | Utilization of Glial Fibrillary Acidic Protein and Galectin-3 in the Diagnosis of Cerebral Infarction Patients with Normal Cranial Tomography [pubmed:28406123] |
Cytokine | Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects [pubmed:29102164] |
Biomedicine & pharmacotherapy | Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms [pubmed:28061403] |
Experimental gerontology | The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling. [pubmed:29107062] |
Pesticide Biochemistry and Physiology | Acrolein-mediated neurotoxicity in growing Wistar male rats [Pubmed:30033014] |
Journal of Perinatal Medicine | Mechanisms of death in structurally normal stillbirths [Pubmed: 30231013] |
Metabolic?Brain?Disease | Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms [Pubmed: 30456649] |
Metabolic?Brain?Disease | Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms [Pubmed: 30421246] |
博士論文 | INSTITUTO DE CIENCIAS BáSICAS Y PRECLíNICAS “VICTORIA DE GIRóN” DEPARTAMENTO DE HISTOLOGíA [] |
Medicina | The Administration of the New Pyrimidine Derivative—4-{2-[2-(3, 4-Dimethoxyphenyl)-Vinyl]-6-Ethyl-4-Oxo-5-Phenyl-4H-Pyrimidine-1-Il} Benzsulfamide Restores the?… [] |
Open Access Macedonian Journal of Medical Sciences | Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy [Pubmed: 32165929] |
NEUROPSYCHOBIOLOGY | Diosgenin Attenuates Cognitive Impairment in Streptozotocin-Induced Diabetic Rats: Underlying Mechanisms [Pubmed: 32526752] |
JAMA Surgery | Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment [Pubmed: 28593326] |
Acta Histochemica | Quercetin mitigates monosodium glutamate-induced excitotoxicity of the spinal cord motoneurons in aged rats via p38 MAPK inhibition [Pubmed: 32622428] |
stanbul Med J | The Predictive Role of Neurobiochemical Markers in Multiple Sclerosis. [] |
Basic and Clinical Neuroscience | Paeonol Protects Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease [33995926] |
pharmacology online | PHARMACOLOGICAL SCREENING OF A POTENTIALLY EFFECTIVE COMPOUND FOR THE TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY??- [] |
Neuropeptides | The bee venom active compound melittin protects against bicuculline-induced seizures and hippocampal astrocyte activation in rats [34808488] |
Neural Plast | P2Y2 Receptor Mediated Neuronal Regeneration and Angiogenesis to Affect Functional Recovery in Rats with Spinal Cord Injury [Pubmed:35154311] |